Your browser is too old
We can't provide a great video experience on old browserUpdate now
The goal of this lecture is to expound about certain Drugs for bone disorders. Section one puts forth an Overview. In the beginning, the educator has shed light on various Disorders of Bone. In addition to this, Bone Remodelling and Drugs Used for Bone Disorders have been brought into debate. Next in line, Site of Action has been conversed about. Conclusively, the educator mentioned about the Pharmacological Control of Osteogenesis.
Bisphosphonates and Estrogen Receptor Modulators
Section two accommodates Bisphosphonates and Estrogen Receptor Modulators. Firstly, Bisphosphonates have been defined. Subsequently, their Mechanism of Action has been brought into discussion. Alongside this, Pharmacokinetics and their Clinical Use has been extensively reported. Moreover, their Adverse Effects and Contraindications have been elucidated. Besides these, Selective Estrogen Receptor Modulator and its Mechanism of Action has been talked about. Moving ahead, modulators` Pharmacokinetics along with the Clinical Use and Adverse Effects has been delineated. In the end, the educator winded up by a dialogue on its Contraindications.
Denosumab and Calcimimetics
The major emphasis of section three is on Denosumab and Calcimimetics. The educator started off by communicating about the Denosumab accompanied by an argument on its Mechanism of Action, Pharmacokinetics as well as its Clinical Use. Moreover, Adverse Effects of Denosumab has been illustrated. Moving further, the educator has shifted our focus on another drug entitled Calcimimetics. Carrying on with the discussion, its Clinical Use along with its Adverse Effects have been brought into reflection. In the end, the curtains have been brought down when the educator referred about Thiazide Diuretics and their Clinical Use.
Other Drugs and Hormone Analogues
Section four highlights Other Drugs and Hormone Analogues. At the onset of this section, a particular type of drug called Strontium Ranelate along with its Mechanism of Action has been laid stress on. Continuing this, its Dosage and Adverse Effects have been outlined. Besides this, Calcitonin, its Clinical Use and Adverse Effects have been reported comprehensively. In the end, the educator has put forward an exhaustive negotiation on Teriparatide.
The cornerstone of section five is Clinical Pharmacology. Firstly, a condition of increased calcium levels called Hypercalcemia has been interpreted in detail. This is succeeded by a comprehensive debate on Hypocalcemia which a condition of lowered calcium levels. This section concluded when the educator stated about two other states termed Hyperphosphatemia and Hypophosphatemia, respectively.